Document is current
Any future updates will be listed below
-
Authors
Gustafsson, Anna https://orcid.org/0009-0008-8321-3525
Hjalte, Frida https://orcid.org/0000-0001-9721-2330
Norlin, Jenny https://orcid.org/0000-0001-5402-1884
Odin, Per https://orcid.org/0000-0002-0756-7478
Hagell, Peter https://orcid.org/0000-0003-2174-372X
-
Funding
Funding for this research was provided by:
Parkinsonfonden (1410/2022)
Kristianstad University
- License Information
-
More Information
Article History
Received: 19 December 2024
Revised: 12 March 2025
Accepted: 14 March 2025
First Online: 28 March 2025
Declarations
:
: AG, FH, PO and PH declare that they have no conflicts of interest. At the time of the study JMN was employed at IHE and had no conflicts of interest to declare. JMN is currently employed by LEO Pharma A/S.
: The study was performed in accordance with the Declaration of Helsinki and was approved by the Swedish Ethical Review Authority, Lund, Sweden (Dnr 2013/374 and 2019/05791). All patients have provided their verbal informed consent to participate in the Swedish Parkinson’s Disease registry. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
